Ann: $1.43M R&D rebate received, page-52

First 52 Last

Share
Profile

Follow
luxury

3,546 Posts.

325

22/11/22

11:07

Post #: 64912852
Share

Originally posted by Michael Yoni: ↑

What would be more robust is after the trial to then remove all antiretrovirals from both groups and see which ones rebound to detectible levels in the plasma. That will see if those treated with 225 have significantly lower reserves stored than the controls.
What would also be on interest is to obtain sequences of the virus before the start and at the end if and when there is detectable viral loads. This would indicate if those still in the reservoirs were the same as at the start of the trial. (sorry this must be my scientists hat coming out). This they can do as they will be collecting and storing both plasma and cellular material during the trial - you would think.

Something that started before 2018 and reported like it was, to me its the lack of peer reviewed papers that is lacking. Presenting at scientific/medical conferences is one thing but publishing it is another. They have the ability to publish these (not on posters as conferences).

LUX, yes, back in the dark ages I was at a conference and met some scientists that were talking about these compounds that were developed and the prelim results were exciting and promising.... that is when I got in. And people are complaining about the current price when buying in at 10c (I cry for them - I really do).

Expand

You should ask Biotron if they intend to do those tests you mention, would be interesting to see their response.

BIT Price at posting: 3.6¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

HVN

Consumers holding back says Harvey Norman, as profit slumps 35% in FY24

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

There are more pages in this discussion • 4 more messages in this thread...

First 52 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 2.8¢		Change 0.000(0.00%)		Mkt cap ! $25.26M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	312047	2.6¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	198191	3

View Market Depth

No.	Vol.	Price($)
2	312047	0.026
6	1398646	0.025
4	396000	0.024
2	430000	0.023
5	4245555	0.022

Price($)	Vol.	No.
0.028	198191	3
0.029	555600	4
0.030	90000	3
0.031	109129	2
0.032	500000	1

Last trade - 10.27am 30/08/2024 (20 minute delay)

BIT (ASX) Chart

Day chart unavailable

Ann: $1.43M R&D rebate received, page-52

Consumers holding back says Harvey Norman, as profit slumps 35% in FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Lendlease sells off US east coast construction operations in latest global divestment push

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: $1.43M R&D rebate received, page-52

Top Stories

Consumers holding back says Harvey Norman, as profit slumps 35% in FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Lendlease sells off US east coast construction operations in latest global divestment push

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News